Legislature(2019 - 2020)CAPITOL 106
04/04/2019 03:00 PM House HEALTH & SOCIAL SERVICES
Note: the audio
and video
recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
| Audio | Topic |
|---|---|
| Start | |
| HB84 | |
| HB89 | |
| HB92 | |
| HB114 | |
| Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
| *+ | HB 84 | TELECONFERENCED | |
| *+ | HB 89 | TELECONFERENCED | |
| *+ | HB 92 | TELECONFERENCED | |
| *+ | HB 114 | TELECONFERENCED | |
| + | TELECONFERENCED |
HB 89-OPIOID PRESCRIPTION INFORMATION
3:31:03 PM
CO-CHAIR ZULKOSKY announced that the next order of business
would be HOUSE BILL NO. 89, "An Act relating to the prescription
of opioids; relating to the practice of dentistry; relating to
the practice of medicine; relating to the practice of podiatry;
relating to the practice of osteopathy; relating to the practice
of nursing; relating to the practice of optometry; and relating
to the practice of pharmacy."
3:31:35 PM
The committee took a brief at-ease.
3:32:09 PM
REPRESENTATIVE TARR moved to adopt the proposed committee
substitute (CS) for HB 89, labeled 31-LS0421\U, Fisher,4/3/19,
as the working draft.
CO-CHAIR ZULKOSKY objected for discussion.
3:32:25 PM
CO-CHAIR SPOHNHOLZ introduced HB 89, explaining that this was
re-visiting a bill that had previously been introduced by
Representation Gara in 2018. She stated that the purpose of the
proposed bill was to ensure that Alaska did everything possible
to reduce access to opioids and the associated unnecessary
risks. She introduced a PowerPoint titled "House Bill 89:
Opioid Addiction Risk Disclosure." She reported that there had
been 100 overdoses from opioids in 2017, and although there had
been progress through a prescription drug monitoring program,
easier disposal of opioids, and a reduction of use, it was still
a problem as 80 percent of addiction to street level heroin
began with legally prescribed opioids, whether or not it was
their legal prescription. She suggested that it was best to
flip the conversation and begin with an introduction to the
risks associated with opioids before they were taken. She
stated that the proposed bill offered "a couple of opportunities
for a patient to be educated about the risks of addiction and
dependence on opioids before they can consume it." She allowed
that there would be exclusions for emergencies and other times
when it was not possible for an informed consent. She offered
her belief that education should take place at multiple points
as research had indicated that it takes multiple times for an
individual to hear a message before the information is
internalized. She paraphrased slide 3, "Research and
Statistics," which read:
A recent meta-analysis of research (Schmidt & Eisend,
2015) published in the Journal of Advertising found
that it takes an average of 8-10 exposures for a
person to remember a concept.
The more often a patient hears a message about
the inherent risks of opioids, the more likely they
are to have an increased awareness of the potential
dangers of physical dependence and addiction.
Statistics on Opioid Misuse and Opioid Related Deaths:
Drug overdose was Alaska's leading cause of
accidental death in 2016 (Alaska Department of Health
and Social Services).
More than 3 out of 5 drug overdoses involve an
opioid (Centers for Disease Control and Prevention, AK
DHSS).
4 out of 5 heroin users started out misusing
prescription opioids (American Society of Addiction
Medicine).
New research (Weinheimer, Michelotti, Silver, Taylor,
& Payatakes, 2018) on effective pain management:
A combination of Ibuprofen 200 mg and
Acetaminophen 500 mg is approximately 3 times more
effective than 15 mg of Oxycodone. (Dr. Don Teater,
Teater Health Solutions).
CO-CHAIR SPOHNHOLZ moved on and paraphrased slide 4, "Goals of
House Bill 89, which read:
Reduce the use of opioids for pain management and
increase use of non-opiate pain management tools and
medications.
Increase communication about the dangers and risks of
opioids.
Decrease opioid misuse and opioid-related deaths in
Alaska.
Mitigate the opioid related public health crisis
Alaska is currently facing.
Provide a positive example to other states in the US
that are facing similar public health crises.
3:36:45 PM
MIRANDA DORDAN, Intern, Representative Ivy Spohnholz, Alaska
State Legislature, paraphrased slide 5, "Section 1: Legislative
Findings" which read:
Legislative findings hold that the state has a moral,
financial, and public health interest in reducing
opioid and heroin addiction in Alaska.
Medically documented evidence finds that opioid
prescription drugs can lead to physical dependence and
potential addiction.
Studies have shown that a significant amount of heroin
users started as opioid drug users.
The Opioid Epidemic increases crime in the state, and
the presence of heroin dealers in the state poses a
public safety threat.
Opioid addictions tear families apart, destroy a
person's ability to hold a job, and decimate lives.
Addiction treatment is costly and hard on families,
affecting quality of life.
Addiction treatment and additional public safety costs
are also expensive for consumers and the state.
3:38:08 PM
MS. DORDAN paraphrased slide 6, "Section 2: Dentists," which
read:
Requires dentists to inform patients of the potential
addictive dangers of opioids and any reasonable
treatment alternatives using oral and written
information before prescribing an opioid.
The State Board of Dental Examiners will craft and
enforce regulations that satisfy requirements of HB
89.
MS. DORDAN directed attention to a handout on the Department of
Health and Social Services website as a visual aide with great
information for opioid statistics specific to Alaska.
3:40:02 PM
CO-CHAIR SPOHNHOLZ pointed out that the bill sponsors did not
want to over prescribe the way this should be implemented at the
Board level, but to instead, allow each of the Boards to
identify for themselves the best way to regulate and manage the
information. She emphasized that the sponsors only wanted to
ensure that providers in Alaska offered oral and written
communication about the risks and alternatives.
3:40:40 PM
MS. DORDAN moved on to paraphrase slide 7, "Section 3: Medical,
Osteopathy, and Podiatry Providers," which read:
Requires Medical, Osteopathy, and Podiatry Providers
to inform patients of the potential addictive dangers
of opioids and any reasonable treatment alternatives
using oral and written information before prescribing
an opioid.
The State Medical Board will craft and enforce
regulations that satisfy requirements of HB 89.
3:41:51 PM
MS. DORDAN directed attention to slide 8, "Section 4: Registered
Nurses," which read:
Requires registered nurses to inform patients of the
potential addictive dangers of opioids and any
reasonable treatment alternatives using oral and
written information before prescribing an opioid.
The Alaska Board of Nursing will craft and enforce
regulations that satisfy requirements of HB 89.
3:42:24 PM
MS. DORDAN shared slide 9 "Section 5: Optometrists," which read:
Requires optometrists to inform patients of the
potential addictive dangers of opioids and any
reasonable treatment alternatives using oral and
written information before prescribing an opioid.
The State Board of Examiners in Optometry will craft
and enforce regulations that satisfy requirements of
HB 89.
3:42:56 PM
MS. DORDAN indicated slide 10 "Section 6: Pharmacists," which
included the changes in the proposed committee substitute,
Version U, which read:
Requires pharmacists to inform patients of the
potential addictive dangers of opioids using oral and
written information before dispensing an opioid.
The Alaska Board of Pharmacy will craft and enforce
regulations that satisfy requirements of HB 89.
3:44:57 PM
MS. DORDAN directed attention to slide 11 "Section: Visual Aid,"
which read in part:
DHSS must create a visual aid that providers can hand
out to patients when they are being prescribed
opioids.
MS. DORDAN reiterated that the handout had already been created
and was on the Department of Health and Social Services website.
3:46:16 PM
MS. DORDAN shared the references and letters of support on slide
12, "Letters of Support:" which included the Alaska Dental
Society and Fallen Up Ministries.
3:46:37 PM
REPRESENTATIVE JACKSON offered her belief that doctors had taken
an oath to do everything within their power to keep their
patients healthy and that there was a federal requirement for
doctors to explain each drug and its side effects. She asked if
the proposed bill was requiring the state to manage doctors for
how they inform and educate their patients.
3:47:37 PM
CO-CHAIR SPOHNHOLZ explained that the proposed bill was designed
to add another layer of education for patients. She shared a
personal experience with opioids and noted that the bill
proposed to begin the conversation in the health care provider's
office. She offered her belief that more conversation would
reduce the number of opioids prescribed, consumed, and
distributed into our communities.
3:49:34 PM
REPRESENTATIVE JACKSON acknowledged awareness for the opioid
crisis, with a variety of organizations enforcing education on
opioids. She asked for clarification that Co-Chair Spohnholz
had been offered medications without any education.
CO-CHAIR SPOHNHOLZ replied that she had been offered opioids by
a full range of medical professionals.
REPRESENTATIVE JACKSON asked if the proposed bill would ensure
monitoring through the various Boards that doctors were offering
this education.
CO-CHAIR SPOHNHOLZ replied that the intent of the proposed bill
was to require medical personnel to educate patients about the
risks associated and give them printed materials to take home.
The proposed bill would give the power to the Boards for
enforcement. She emphasized that it was not intended to define
in law specific steps that should be taken. She offered her
belief that a way to build consensus was to allow the
professionals to determine the best way to regulate and enforce.
3:51:51 PM
REPRESENTATIVE JACKSON acknowledged that "the idea and the
intention is fabulous" but asked if there had been discussions
with the various boards for a timeframe. She suggested that
enforcement legislation may be necessary if the boards did not
comply.
CO-CHAIR SPOHNHOLZ shared the history of a prior compromise to
allow Department of Health and Social Services to create and
distribute information. However, it had been decided that it
was time to introduce legislation, as the boards had a limited
scope of responsibility and needed a law in order to take on new
regulations. She stated that she had been talking with
providers to craft a bill that was practical while achieving the
public health goal for reduction of opioid dependence.
3:53:49 PM
REPRESENTATIVE DRUMMOND directed attention to slide 2 and
expressed her surprise regarding the combination of ibuprofen
and acetaminophen as three times more effective than 15 mg of
oxycodone. She asked if this was a prescription combination or
was it available over the counter.
CO-CHAIR SPOHNHOLZ explained that the combination was a legal
over the counter level for each of those medications. She
acknowledged that this combination was so much more effective
than opioids.
3:55:44 PM
REPRESENTATIVE DRUMMOND directed attention to slide 3 and
expressed that she was impressed with the 36 percent decrease in
opioid overdoses and a 67 percent decrease in fentanyl
overdoses. She asked if each overdose resulted in death.
CO-CHAIR SPOHNHOLZ clarified that these were overdose related
deaths and not just overdoses. She reported that overdose death
had decreased with the broad distribution of naloxone as it
allowed emergency responders to reverse an overdose.
3:57:28 PM
REPRESENTATIVE DRUMMOND referred to slide 7 and asked about
exemptions for palliative and hospice care.
MS. DORDAN explained that these exemptions could be offered
although ultimately the Board would decide who was exempt.
CO-CHAIR SPOHNHOLZ added that, as the delivery of health care
was very complex, it was the intention not to define in law
exactly where the education should take place and that, instead,
the medical professionals make that decision. She noted that
the implementation could be addressed later if there were
concerns.
3:59:12 PM
REPRESENTATIVE DRUMMOND pointed to slide 9 and asked about
treatments performed by optometrists which required an opioid.
CO-CHAIR SPOHNHOLZ explained that, although it was not routine
care, optometrists could perform some minor procedures which
could create some pain and necessitate the prescription of pain
medication.
4:00:34 PM
CO-CHAIR ZULKOSKY removed her objection. There being no further
objection, the proposed committee substitute (CS) for HB 89,
labeled 31-LS0421\U, Fisher,4/3/19, was adopted as the working
draft.
4:01:05 PM
CO-CHAIR ZULKOSKY opened public testimony.
4:01:22 PM
CO-CHAIR ZULKOSKY said she would keep public testimony open.
[HB 89 was held over.]
| Document Name | Date/Time | Subjects |
|---|---|---|
| HB084 Sectional Analysis 4.3.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/25/2019 3:00:00 PM HL&C 2/26/2020 3:15:00 PM |
HB 84 |
| HB084 Sponsor Statement 3.28.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/25/2019 3:00:00 PM HL&C 2/26/2020 3:15:00 PM |
HB 84 |
| HB084 Supporting Document- Breast Cancer in Women Firefighters.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/25/2019 3:00:00 PM HL&C 2/26/2020 3:15:00 PM |
HB 84 |
| HB084 Supporting Document- Letter of Support ACAT 4.3.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/25/2019 3:00:00 PM HL&C 2/26/2020 3:15:00 PM |
HB 84 |
| HB084 Supporting Document- Asbestos 03.28.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/25/2019 3:00:00 PM HL&C 2/26/2020 3:15:00 PM |
HB 84 |
| HB084 Supporting Document- RADS in Police from Chemical Spill 3.28.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/25/2019 3:00:00 PM HL&C 2/26/2020 3:15:00 PM |
HB 84 |
| HB084 Fiscal Note DLWD WC 04.03.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/25/2019 3:00:00 PM HL&C 2/26/2020 3:15:00 PM |
HB 84 |
| HB084 Letter of Support- APOA 3.28.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/25/2019 3:00:00 PM HL&C 2/26/2020 3:15:00 PM |
HB 84 |
| HB084 Opposition Document- AML Joint Insurance Association 3.29.2019.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/25/2019 3:00:00 PM HL&C 2/26/2020 3:15:00 PM |
HB 84 |
| HB084 Presentation 4.3.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/25/2019 3:00:00 PM |
HB 84 |
| HB0089 Supporting Document-DHSS Handout 03.27.2019.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 89 |
| HB0089 Supporting Document-Support Letter 04.03.2019.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 89 |
| HB0089 Supporting Document-Support Letters 1.27.2019.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 89 |
| HB0089-Opposing Document-Opposition Letter 04.03.2019.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 89 |
| HB0089 Draft Proposed Blank CS ver U 04.03.2019.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 89 |
| HB0089 Explanation of Changes ver U 04.03.2019.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 89 |
| HB0089 Sectional Analysis ver A 03.27.2019.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 89 |
| HB0089 Sponsor Statement 03.27.2019.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 89 |
| HB092 ver U 3.27.19.PDF |
HHSS 4/4/2019 3:00:00 PM |
HB 92 |
| HB92 Fiscal Note DCCED-IO 3.31.2019.pdf |
HHSS 4/4/2019 3:00:00 PM |
HB 92 |
| HB92 Fiscal Note DHSS-MS 3.31.2019.pdf |
HHSS 4/4/2019 3:00:00 PM |
HB 92 |
| HB92 Sponsor Statement 3.31.19.pdf |
HHSS 4/4/2019 3:00:00 PM |
HB 92 |
| HB092 Sectional Analysis ver U 3.27.19.pdf |
HHSS 4/4/2019 3:00:00 PM |
HB 92 |
| HB114 Letters of Support 04.03.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 114 |
| HB114 Sectional Analysis 04.03.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 114 |
| HB114 SHARP-2 Final Report to Legislature 04.01.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 114 |
| HB114 Sponsor Statement 04.03.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 114 |
| HB114 DHSS Presentation 04.01.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 114 |
| HB114 Fiscal Note DCCED CBPL 04.01.19.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 114 |
| HB089 ver U Presentation.pdf |
HHSS 4/4/2019 3:00:00 PM HHSS 4/9/2019 3:00:00 PM |
HB 89 |